No Data
Olema in Deal With Novartis on Kisqali Breast Cancer Combo Collaboration
PTC Therapeutics Strikes Up to $2.9 Billion Licensing Deal With Novartis for Huntington's Disease Drug Candidate
Sector Update: Health Care Stocks Mixed Pre-Bell Monday
Sector Update: Health Care
ptc therapeutics (PTCT.US) signed a Huntington's disease drug licensing agreement with novartis ag (NVS.US).
The stock price of ptc therapeutics (PTCT.US) rose 21% in pre-market trading on Monday.
PTC Therapeutics Signs Exclusive Global License And Collaboration Agreement With Novartis; PTC To Receive Upfront Payment Of $1B, Up To $1.9B In Development, Regulatory And Sales Milestones
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
103827296 : Halo Medan hai hai English understand I'm sorry
72627089 : fractional shares
72627089 : would like to chat about fractional shares
(R-long)103834298 : stop all
l0lBElBgG : k